Skip to content

MassBio

Massachusetts Biotechnology Council

Open search form
  • Sign In
  • Become a Member
  • MB Vision
  • Members
    • Become a Member
      • Types & Rates
    • Benefits
      • Savings and Rewards
    • Member News
    • Member Events
    • Career Center
    • Directory
    • Pay Company Dues
    • FAQs
  • Events
    • Upcoming
    • Types of Events
    • Sponsorship Opportunities
    • The State of Possible Conference
    • Align Summit
    • Member Events
  • Innovation
    • About
    • Drive
      • Application
      • Alumni
      • Partners – MassBio
      • Partners – SCbio
      • Get Involved
      • FAQs
    • CEO & Founder Link
    • Align Summit
    • Partnering
    • Sponsorship Opportunities
  • Savings
    • MassBioEdge
  • Conference Center
    • About MassBioHub
    • Packages & Special Offers
    • Venue Specifications
    • Reserve Today
  • Policy & Advocacy
    • Policy & Advocacy Efforts
    • Diversity, Equity, and Inclusion
      • DEI Report
      • Resource Center
      • Open Letter 2.0
      • Bioversity
    • Economic Development
      • BioReady® Communities
    • Workforce Development
      • Bioversity
    • Vision 2030
    • This is the place.
    • Industry Reports
      • Federal Actions Impact Report
      • Industry Snapshot
      • Biopharma Funding Report
      • DEI Report
      • MA Life Sciences Workforce
  • About
    • About MassBio
    • News & Thought Leadership
    • MB Vision
    • The Studio at Kendall Square
    • Sponsorship Opportunities
    • Staff
    • Board
    • Contact Us
  • Sign In
  • Become a Member
  • MB Vision
Open search form

Member Directory

Click to Open Main Menu

SEQENS CDMO NA

Life Sciences | Contract Research & Manufacturing
Devens, MA (781) 727-1770 Website @Seqens_CDMO LinkedIn

Overview

SEQENS is a worldwide leader in developing and
producing active ingredients, pharmaceutical intermediates, specialty
ingredients, and cosmetics & personal care, leveraging 16 manufacturing
sites, 9 R&D centers, and 3,300 employees in 9 countries. As an integrated
player across the value chain – from raw materials to active ingredients and
from research and development to industrialization – SEQENS offers a broad
portfolio of active ingredients, pharmaceutical intermediates, and specialty
ingredients, develops, and industrializes the most demanding molecules, and
relies on its ability to innovate, develop, and implement the best available
technologies.
 
Driven not only by a culture of excellence and
a strong entrepreneurial spirit but also strong values such as unity, agility,
and reactivity, our employees are committed to providing the highest level of
service and quality to more than 1500 customers around the world while acting
ethically in accordance with our strong Environmental, Social, and Governance
program.

 

Located in Devens (MA) for 20 years, SEQENS
Boston’Lab has acquired a strong expertise in developing custom New Chemical
Entities for pharmaceutical purposes. It combines the responsiveness of a small
company with the capacity and capabilities of a much larger one. Our
2023-inaugurated Innovation Center includes R&D labs and GMP suites for
non-GMP and GMP manufacturing, from grams to kilograms.

Company News

News

Seqens Group Opens Flagship Pharmaceutical R&D Center in Greater Boston

Feb 09, 2023

Posted by SEQENS CDMO NA

News

SEQENS Makes Multi-Million-Dollar Investment in U.S. R&D Laboratory (Devens, MA)

Mar 31, 2022

Posted by SEQENS CDMO NA

See all Members

Massachusetts Biotechnology Council

700 Technology Square, 5th Floor
Cambridge, MA 02139
617.674.5100

  • News & Thought Leadership
  • Pay Company Dues
  • Join Today
  • Contact
  • Privacy Policy
  • © 2025 All Rights Reserved